Press Releases

NextBeam Earns Rigorous MedAccred Sterilization Accreditation Jun 3, 2024 05:00AM

MedAccred� recognizes NextBeam for its commitment to continual improvement in medical device quality.

NORTH SIOUX CITY, SD / ACCESSWIRE / June 3, 2024 / NextBeam, a leading provider of Electron Beam irradiation services, proudly announces its achievement of the MedAccred� Sterilization accreditation following the successful completion of audit number 2007683. This prestigious certification, granted by the Performance Review Institute (PRI), underscores NextBeam's... (continue reading...)

Kantor & Kantor, LLP Strengthens Client Service and Firm Leadership With Three Attorney Promotions Jun 3, 2024 05:00AM

NORTHRIDGE, Calif., June 3, 2024 /PRNewswire/ -- Kantor & Kantor, LLP, a preeminent plaintiff law firm with a successful appeals and litigation practice advocating for policyholders' insurance and plan participant retirement benefit rights, proudly announces several key promotions within its legal leadership team.

Kantor & Kantor, LLP Advances Three... (continue reading...)

Attain taps Mediaocean's Ben Kartzman as president, COO Jun 3, 2024 05:00AM

NEW YORK, June 3, 2024 /PRNewswire/ -- Attain, the largest permission-based purchase data platform in the U.S., has hired industry veteran Ben Kartzman as its first President and Chief Operating Officer (COO).

Kartzman joins the company after nearly three years as COO at Mediaocean. He also served as President of Flashtalking, an ad server which was... (continue reading...)

Enhanced Games Responds to FIMS Statement on Safety in Sports Jun 3, 2024 05:00AM

• Enhanced Games align with the ethos of healthy athletes and fair competition by promoting clinically supervised performance enhancements.
• Seeks to facilitate better performance enhancement research and strategies through transparency and scientific oversight.
• Calls for dialogue and collaboration with FIMS and other stakeholders.

LONDON, June 3, 2024 /PRNewswire/ -- In response to the recent position statement by the International Federation of Sports Medicine (FIMS)... (continue reading...)

QurAlis Grants Lilly Exclusive Global License for QRL-204, a Potentially First-in-Class Precision Therapy That Restores UNC13A Function in ALS and FTD Jun 3, 2024 05:00AM

QRL-204 is a splice-switching ASO generated through QurAlis' FlexASO™ Platform; represents Lilly's first program targeting UNC13A in ALS and FTD

Parties to also collaborate to leverage QurAlis' ALS and ASO development expertise to advance QRL-204 and next-generation compounds

UNC13A is an essential regulator of neurotransmitter release at synapses; mis-splicing is a critical RNA alteration occurring in up to 63 percent of all ALS patients and up to one-third of all... (continue reading...)